Search

everythinglearnresearchcommunity

for

Search:↓

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

A rare skin reaction from laser hair removal can be prevented with medication.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Upadacitinib effectively treats pyoderma gangrenosum.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

A man's skin condition was misdiagnosed and later identified as a rare type of skin cancer, which did not improve with treatment.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

A black-skinned woman was diagnosed with Vogt-Koyanagi-Harada disease and treated with steroids and eye drops.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Improper steroid use can cause skin issues like rosacea, which may improve after stopping the steroid and using benzoyl peroxide.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Skin reactions to antidepressants are common but usually not serious and can be treated.